|
|
||||
|
An Onus on Conus
The Scientist 2005, 19(Supplement 1):s32
|
||||
|
|
||||
|
This past December, the US Food and Drug Administration approved Prialt, Elan Corporation's synthetic version of a peptide from the venomous sea snail Conus magus. The drug, ziconotide, is the first of its kind and appears to alleviate severe pain by blocking N-type Ca+ channels.
|